Peptide Recall 2026: Glutathione Endotoxin Risk, 14 States

Compounded glutathione injections from Optimal Balance Pharmacy have been recalled for elevated endotoxin risk; check your vial lot LG342009076. The Houston pharmacy pulled one lot of Compounded Glutathione 200 mg/mL 30 mL multi-dose vials distributed to 14 states after its own testing found elevated endotoxin. It is the second Texas compounding pharmacy in two weeks to recall injectable glutathione for the same defect — an active peptide recall 2026 event.

Safety callout — check your vial now. If you received a glutathione injection supplied by Optimal Balance Pharmacy or Victory Medical Center Pharmacy, find the vial’s lot number and compare it against the recall lists below. If it matches, stop using it immediately, quarantine the vial, and contact the pharmacy. Seek emergency care for difficulty breathing, chest pain, fainting, throat or facial swelling, a rapidly spreading rash, or a sudden fever above 102°F after an infusion.

What happened and why it matters

The Optimal Balance recall: one lot, 14 states

Optimal Balance Pharmacy (Houston, Texas) announced a voluntary nationwide patient-level recall on August 19, 2026; the FDA published it August 20. The recall covers Compounded Glutathione 200 mg/mL, 30 mL multi-dose vials — lot LG342009076, expiring October 4, 2026 — pulled because pharmacy testing identified elevated bacterial endotoxin levels. Distribution reached 14 states: Arizona, Colorado, Florida, Illinois, Louisiana, Michigan, Nevada, New York, Oklahoma, Pennsylvania, Texas, Utah, Vermont, and Washington. Most 503A compounders answer to state boards, not federal inspectors — one reason states are filling the federal oversight gap.

The second recall: Victory Medical Center Pharmacy

Two weeks earlier, Victory Medical Center Pharmacy (Austin, Texas) recalled three lots of the same product on August 5, 2026, FDA-published the same day: lots 1980571, 1981940, and 1984345 (exp. August 27, 2026), distributed in Texas, Florida, and New York.

What elevated endotoxin means

Bacterial endotoxin is a fragment of gram-negative bacteria’s outer membrane — not a live infection, and it can persist after sterilization. Injected into the bloodstream, it triggers a rapid inflammatory response within minutes to hours.

Both FDA notices carry the same risk statement: “There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death.” That language is the companies’ own assessment, not an FDA finding of harm in these patients; neither notice discloses hospitalizations or deaths.

Reported reactions include fever, chills, severe headache, nausea, vomiting, and pain; Victory also lists tachycardia, blood pressure changes, body aches, and injection-site reactions. The failure mode has precedent: in 2019 the FDA warned compounders against L-glutathione from Letco Medical after seven patients reacted within minutes of an IV infusion (one hospitalized), with endotoxin up to five times the limit.

Independent testing catches more than endotoxin: dose, purity and identity results from third-party laboratories are collected in the 9,997-test dataset, while sterility, particulates and stability sit outside a standard certificate of analysis.

Injectable glutathione is not an FDA-approved drug; it is compounded and marketed off-label for skin brightening, cellular detoxification, and immune support, with no FDA review for safety or effectiveness. That gap is why ECRI and ISMP have warned on wellness peptide safety and why FDA compounding enforcement has intensified.

How to check if your glutathione peptide is affected

Your peptide batch is safe if its lot number does not match an active recall. Optimal Balance Pharmacy recalled lot LG342009076 (exp. Oct 4, 2026) after testing found elevated endotoxin levels. Check the vial label, compare the lot number, and stop using the vial if it matches.

Find the lot number

The lot number and expiration date are printed on the vial label. If you never saw the vial — common with clinic-administered infusions — ask the clinic or med spa which pharmacy supplied the product and which lot was used.

Search the FDA recall database

Search the FDA Recalls, Market Withdrawals & Safety Alerts page for “Optimal Balance” or “glutathione” to confirm the current notices. (The older dedicated search-database URL 404s as of August 2026; use the main page.)

If your vial matches a recalled lot

1. Stop using the product immediately and quarantine the vial — do not discard it; the pharmacy will arrange retrieval.
2. Contact the pharmacy to arrange retrieval. Optimal Balance’s FDA notice lists (218) 919-2964, 9am–5pm CST Monday–Friday; the pharmacy’s own notice and contact page list (281) 919-2964 at 2204 Cypress Creek Pkwy Suite F, Houston, TX 77090. Victory Medical Center Pharmacy: (512) 279-0985.
3. Expect a full refund if not already reimbursed.
4. Report any reaction to your prescribing physician and to FDA MedWatch (www.fda.gov/medwatch/report.htm or 1-800-332-1088).

Before your next compounded peptide order, use the 10-point compounding pharmacy verification checklist — license status, state oversight, and lot-level testing history separate a careful 503A pharmacy from one in a recall notice. And when the vial came from a clinic or med spa, the guide to what to ask before getting compounded GLP-1s or peptides applies the same 503A/503B and inspection-history checks to that supply route.

FAQ

Are compounded peptides safe?

Compounded peptides are only as safe as the pharmacy that makes them and the testing behind each batch. Compounded drugs are not FDA-approved and undergo no premarket review. Verify your pharmacy’s state license and ask for lot-specific endotoxin and sterility test results.

Was glutathione injection recalled?

Yes. On August 19, 2026, Optimal Balance Pharmacy (Houston, TX) recalled Compounded Glutathione 200 mg/mL 30 mL multi-dose vials, lot LG342009076, over elevated endotoxin levels. Two weeks earlier, Victory Medical Center Pharmacy (Austin, TX) recalled three lots of the same product for the same reason.

Which lots of glutathione were recalled?

Optimal Balance Pharmacy: lot LG342009076 (exp. Oct 4, 2026), in 14 states. Victory Medical Center Pharmacy: lots 1980571, 1981940, and 1984345 (exp. Aug 27, 2026), in Texas, Florida, and New York. Check your vial label against both lists — they are different lots.

How do I check my peptide lot for a recall?

Find the lot number on the vial label, or ask the clinic which pharmacy supplied the product and which lot was used. Compare it against the notices above and the FDA recalls page at fda.gov. If your lot matches, stop using the vial, quarantine it, and contact the pharmacy for a refund.

What are the symptoms of an endotoxin reaction?

Fever, chills, severe headache, nausea, vomiting, rapid heartbeat, and blood pressure changes — typically within minutes to a few hours of injection. Severe cases: anaphylactic shock, difficulty breathing, chest pain, fainting, or throat and facial swelling, which require emergency care.

What should I do if I have the recalled glutathione?

Stop using it immediately and quarantine the vial. Contact Optimal Balance Pharmacy at (281) 919-2964 (also (218) 919-2964 in the FDA notice) or Victory Medical Center Pharmacy at (512) 279-0985 to arrange retrieval and a full refund. Contact your clinician if you have had symptoms, and report reactions to FDA MedWatch.

What to watch next

Both recalls are voluntary, patient-level actions; state boards may act next since 503A pharmacies are primarily state-overseen. For the broader picture — the April reclassification, the July PCAC recommendations, and what comes next — follow the 2026 FDA peptide regulatory timeline. For harm documented outside the licensed channel, see the online-sourced retatrutide case report. If you hold product from either pharmacy, check your lot today.

PeptidesBeat is an independent editorial publication covering peptide policy, research, and industry developments. We do not sell peptides, recommend dosing, or provide medical advice. All content is informational. Peptides referenced may be subject to FDA restrictions; consult a licensed healthcare provider for any therapeutic question.